Articles

Quick View: South Korea’s Growth Outlook Brightens

Country Risk / South Korea / Thu 25 Apr, 2024

Latest Development: Data released on April 25 showed South Korea’s real GDP expanding in Q124 by a seasonally-adjusted 1.3% q-o-q, accelerating from 0.6% in Q423. This corresponded to a 3.4% y-o-y growth.

Forecast Implications: The outturn surprised significantly to the upside, surpassing both our and the consensus estimate of a 2.4% y-o-y

Read More

Vietnam: Weak Dong Will Not Stop Rate Cuts

Banking & Financial Services / Vietnam / Thu 25 Apr, 2024

Key View

  • We maintain our forecast for the central bank to cut its policy rate from 4.5% to 4.0% by end-2024.
  • We think the Bank will ease policy further to help ensure the economy meets the government’s GDP and credit growth targets, and relatively benign inflation will allow the Bank to cut.
  • While recent dong weakness is a constraint, we
Read More

Roche’s Bispecific Antibody Columvi Gains Edge On AbbVie And Genmab’s Epkinly Following Latest Data

Oil & Gas / United States / Tue 23 Apr, 2024

Key View

  • Roche’s latest Columvi data will support the drug’s full approval in the US and Europe.
  • Approval as an earlier line treatment will give Roche an edge over AbbVie and Genmab’s Epkinly.
  • Bispecific therapies will continue to attract interest from cancer drugmakers.

Roche’s latest Columvi (glofitamab) data will support the drug’s

Read More
Download Indicator Summary
 

Thank you. Your download link will be emailed to you shortly.

Download Now
 

Thank you. Your download link will be emailed to you shortly.

Download Now
 

Thank you. Your download link will be emailed to you shortly.

Clearbit Form
 

Thank you. Your download link will be emailed to you shortly.